Genovate Biotechnology Co (ROCO:4130) Total Stockholders Equity : NT$1,490.8 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Genovate Biotechnology Co Total Stockholders Equity?

Genovate Biotechnology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was NT$1,490.8 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Genovate Biotechnology Co's Book Value per Share for the quarter that ended in Mar. 2024 was NT$13.63. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Genovate Biotechnology Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Genovate Biotechnology Co Total Stockholders Equity Historical Data

The historical data trend for Genovate Biotechnology Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovate Biotechnology Co Total Stockholders Equity Chart

Genovate Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,408.23

1,425.96

1,378.87

1,410.83

1,468.77

Genovate Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															1,503.27	1,483.63	1,467.14	1,468.77	1,490.82

Genovate Biotechnology Co (ROCO:4130) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Genovate Biotechnology Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1490.822	-	0)	/	109.376
	=	13.63

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Genovate Biotechnology Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.324	+	0)	/	1490.822
	=	0.00

Genovate Biotechnology Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Genovate Biotechnology Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Genovate Biotechnology Co (ROCO:4130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovate Biotechnology Co Ltd (ROCO:4130) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1, First Industrial Road, Hsin-Chu Industrial Zone, Guangdong Province, Hsin-Chu, TWN

Website

http://www.genovate-bio.com

Genovate Biotechnology Co Ltd develops, manufactures and markets pharmaceutical preparations, drug substances and intermediates. Its product line includes nervous system drugs, digestive system drugs and cardiovascular system drugs, among others. It also provides clinical trial services for various drugs.

Genovate Biotechnology Co (ROCO:4130) Headlines

No Headlines